New Vernon Investment Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$634K Hold
7,313
0.67% 36
2025
Q4
$702K Hold
7,313
0.68% 33
2025
Q3
$696K Hold
7,313
0.65% 37
2025
Q2
$637K Hold
7,313
0.74% 32
2025
Q1
$657K Sell
7,313
-22,300
-75% -$2M 0.88% 31
2024
Q4
$2.42M Buy
29,613
+22,300
+305% +$1.93M 3.2% 12
2024
Q3
$658K Hold
7,313
0.71% 33
2024
Q2
$576K Hold
7,313
0.75% 33
2024
Q1
$637K Buy
7,313
+3,029
+71% +$259K 0.54% 30
2023
Q4
$353K Hold
4,284
0.41% 35
2023
Q3
$336K Buy
+4,284
New +$359K 0.51% 32

Other funds holding MDT

New Vernon Investment Management's MDT Position: Q1 2026 in Review

New Vernon Investment Management held its Medtronic (MDT) position steady in Q1 2026 at 7,313 shares worth $634K. The position accounts for 0.67% of the portfolio, ranked #36.

New Vernon Investment Management first reported a position in MDT in Q3 2023 and has held it in 11 quarters since. The position peaked at $2.42M in Q4 2024. 2,230 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • New Vernon Investment Management held 7,313 shares of Medtronic worth $634K as of Q1 2026.
  • New Vernon Investment Management left its Medtronic share count unchanged in Q1 2026.
  • Medtronic made up 0.67% of New Vernon Investment Management's portfolio in Q1 2026, its #36 holding.
  • New Vernon Investment Management first reported a position in Medtronic in Q3 2023 and has held it in 11 quarters since.
  • New Vernon Investment Management's Medtronic position peaked at $2.42M in Q4 2024.
  • 2,230 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on New Vernon Investment Management's 13F filing for Q1 2026, filed 15 May 2026.